Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features
about
Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of LifeCurrent Immunotherapies for Sarcoma: Clinical Trials and RationaleHow Precisely Can Prostate Cancer Be Managed?Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.Invited commentary on GETUG-AFU 16.Understanding Racial and Ethnic Disparities in Postsurgical Complications Occurring in U.S. Hospitals.A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.Improving postoperative radiotherapy following radical prostatectomy.Changing attitudes towards management of men with locally advanced prostate cancer following radical prostatectomy: A follow-up survey of Australia-based urologists.[Postoperative radiation therapy for prostate cancer : Still no genomic risk profiling for clinical routine].Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial.
P2860
Q26751574-F3AE930C-EDEC-4722-883E-53894C08C87FQ28067036-2C5976D3-8FE4-4D11-A5C8-34A67A12412EQ28078942-AEDF2808-8BFD-42D9-8ED8-0DCE05E5FE44Q30385364-09411744-90B3-41F3-B366-FD9A0BDE5AEEQ36406333-CE469521-350C-4ED0-AB87-E00EE61C5652Q36945088-1A333643-82E4-4F88-BA37-CDF6CC32F99CQ39356227-8C196A43-F04F-49DA-99A9-7E2B2436DBB3Q39790285-AB01C3B4-9209-4770-9EBB-17FD07C9D8F1Q39926873-4B1A0EA3-E0A0-4215-8864-D2A3DA1B889FQ40584866-B613CF26-D627-46A6-B51E-0ABDB5445738Q47958495-18BA8382-3241-4539-8E5B-0B8D95EA92F3Q47978964-93A8F665-70E1-4FD6-94FA-47DC401C9AB1Q48184933-83DF28F9-BC60-4E77-8ADB-0343981804EEQ49823072-87DED016-A39F-47DF-8E7E-F50DED3F927BQ51009611-A4EA2B40-55AA-4252-A412-9C0C762CF9D3Q52660166-300E03B9-A635-49E9-85D1-40F8339F8F93
P2860
Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Low rates of adjuvant radiatio ...... high-risk pathologic features
@ast
Low rates of adjuvant radiatio ...... high-risk pathologic features
@en
Low rates of adjuvant radiatio ...... high-risk pathologic features
@nl
type
label
Low rates of adjuvant radiatio ...... high-risk pathologic features
@ast
Low rates of adjuvant radiatio ...... high-risk pathologic features
@en
Low rates of adjuvant radiatio ...... high-risk pathologic features
@nl
prefLabel
Low rates of adjuvant radiatio ...... high-risk pathologic features
@ast
Low rates of adjuvant radiatio ...... high-risk pathologic features
@en
Low rates of adjuvant radiatio ...... high-risk pathologic features
@nl
P2093
P2860
P356
P1433
P1476
Low rates of adjuvant radiatio ...... high-risk pathologic features
@en
P2093
Justin E Bekelman
Marc C Smaldone
Nandita Mitra
Robert G Uzzo
Robert Sunderland
Samuel Swisher-McClure
P2860
P304
P356
10.1002/CNCR.28856
P407
P577
2014-06-10T00:00:00Z